Publications

Search results

Journal Article (7)

  1. Journal Article
    Kalbfuss, B.; Flockerzi, D.; Seidel-Morgenstern, A.; Reichl, U.: Size-exclusion chromatography as a linear transfer system: Purification of human influenza virus as an example. Journal of Chromatography B 873 (1), pp. 102 - 112 (2008)
  2. Journal Article
    Kalbfuss, B.; Knöchlein, A.; Kröber, T.; Reichl, U.: Monitoring Influenza Virus Content in Vaccine Production: Precise Assays for the Quantitation of Hemagglutination and Neuraminidase Activity. Biologicals 36 (3), pp. 145 - 161 (2008)
  3. Journal Article
    Kalbfuss, B.; Genzel, Y.; Wolff, M. W.; Zimmermann, A.; Morenweiser, R.; Reichl, U.: Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnology and Bioengineering 97 (1), pp. 73 - 85 (2007)
  4. Journal Article
    Kalbfuss, B.; Wolff, M. W.; Morenweiser, R.; Reichl, U.: Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnology and Bioengineering 96, pp. 932 - 944 (2007)
  5. Journal Article
    Kalbfuss, B.; Wolff, M. W.; Geisler, L.; Tappe, A.; Wickramasinghe, R.; Thom, V.; Reichl, U.: Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. Journal of Membrane Science 299, pp. 251 - 260 (2007)
  6. Journal Article
    Kalbfuss, B.; Reichl, U.: Preparative Size-Exclusion Chromatography. GIT Laboratory Journal Europe 10 (4), pp. 18 - 20 (2006)
  7. Journal Article
    Wickramasinghe, S. R.; Kalbfuss, B.; Zimmermann, A.; Thom, V.; Reichl, U.: Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Biotechnology and Bioengineering 92 (2), pp. 199 - 208 (2005)

Talk (9)

  1. Talk
    Genzel, Y.; Kalbfuss, B.; Ritter, J. B.; Schulze-Horsel, J.; Rapp, E.; Vester, D.; Reichl, U.: Characterization and analytical issues on an influenza A virus production process. Vaccines : Quality control, scale-up and manufacture, Hamburg, Germany (2006)
  2. Talk
    Kalbfuss, B.; Gedicke, K.; Seidel-Morgenstern, A.; Reichl, U.: Maximizing productivity in size-exclusion chromatography of influenza virus: A modelling approach. ESBES 6 : 6th European Symposium on Biochemical Engineering Science, Salzburg, Austria (2006)
  3. Talk
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Best, C.; Morenweiser, R.; Reichl, U.: A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culture. Vaccine Technology, Puerto Vallarta, Mexico (2006)
  4. Talk
    Kalbfuss, B.; Wolff, M. W.; Genzel, Y.; Zimmermann, A.; Morenweiser, R.; Reichl, U.: Chromatography-based purification of influenza A virus for the production of human whole-virion vaccines. ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and Polynucleotides, Innsbruck, Austria (2006)
  5. Talk
    Kalbfuss, B.; Wolff, M. W.; Geisler, L.; Thom, V.; Reichl, U.: Konzentrierung und Aufreinigung von Influenza Viren mittels Ionenaustauscher-Membranen. 24. DECHEMA-Jahrestagung der Biotechnologen, Wiesbaden, Germany (2006)
  6. Talk
    Wolff, M. W.; Kalbfuss, B.; Opitz, L.; Zimmermann, A.; Lehmann, S.; Reichl, U.: Downstream Process of Influenza Viruses. European BioPharm Scale-Up Congress 2006, Geneva, Switzerland (2006)
  7. Talk
    Wolff, M. W.; Kalbfuss, B.; Lehmann, S.; Morenweiser, R.; Opitz, L.; Zimmermann, A.; Reichl, U.: Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza Virus. BioProcess Technology - Asia, Singapore (2006)
  8. Talk
    Wolff, M.; Kalbfuss, B.; Morenweiser, R.; Zimmermann, A.; Reichl, U.: Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion Vaccines. Viral Vectors and Vaccines Conference, Austin, Texas (2005)
  9. Talk
    Wolff, M. W.; Salaklang, J.; Opitz, L.; Schwarzer, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccines. AICHE Annual Meeting 2005, Cincinnati, Ohio, USA (2005)

Poster (3)

  1. Poster
    Opitz, L.; Wolff, M. W.; Salaklang, J.; Rapp, E.; Kalbfuss, B.; Reichl, U.: Lectin-affinity purification of cell culture derived human Influenza A viruses. Vaccine Technology 2006, Puerto Vallarta, Mexico (2006)
  2. Poster
    Kalbfuss, B.; Zimmermann, A.; Wickramasinghe, B.; Morenweiser, R.; Reichl, U.: Tangential Flow Filtration of Influenza Virus as a Model System. Engineering with Membranes, Camogli, Italy (2005)
  3. Poster
    Kalbfuss, B.; Zimmermann, A.; Genzel, Y.; Reichl, U.: Generic Process Scheme for Particle-Based Purification of Cell Culture Derived Influenza A Virus. Bioperspectives, Wiesbaden, Germany (2005)

Thesis - PhD (1)

  1. Thesis - PhD
    Kalbfuß, B.: Downstream Processing of Influenza Whole-Virions for Vaccine Production. Dissertation, 217 pp., Otto-von-Guericke-Universität, Magdeburg (2009)
 
loading content
Go to Editor View